Janssen-Cilag International N.V
SpainAll drugs from this manufacturer
-
It is used to treat adult men with prostate cancer who have abnormalities in certain genes and whose cancer has spread to other parts of the body, and whose cancer no longer responds to medical or surgical treatments that reduce testosterone.
Dosage form: tablets, film-coated
Active substance Dosage niraparib tosylate monohydrate 159,40 mg abiraterone acetate 500 mg -
It is used to treat adult men with prostate cancer who have alterations in certain genes and whose cancer has spread to other parts of the body, and who no longer respond to medical or surgical treatment that reduces testosterone.
Dosage form: tablets, film-coated
Active substance Dosage niraparib tosylate monohydrate 79,70 mg abiraterone acetate 500 mg -
It is used in adults to treat urothelial carcinoma (bladder and urinary tract cancer) that is locally advanced and unresectable, or metastatic, provided the cancer has specific alterations in the FGFR3 gene and has worsened after immunotherapy treatment.
Dosage form: tablets, film-coated
Active substance Dosage erdafitinib 3 mg -
It is used in adults to treat locally advanced and unresectable or metastatic urothelial carcinoma (cancer of the bladder and urinary tract), provided that the cancer cells have FGFR3 gene alterations and the cancer has progressed following immunotherapy.
Dosage form: tablets, film-coated
Active substance Dosage erdafitinib 5 mg -
It is used in adults to treat locally advanced unresectable or metastatic urothelial carcinoma (cancer of the bladder and urinary tract), provided that the cancer presents certain alterations in the FGFR3 gene and has worsened following immunotherapy treatment.
Dosage form: tablets, film-coated
Active substance Dosage erdafitinib 4 mg -
It is used as maintenance treatment to combat the symptoms of schizophrenia in adult patients.
Dosage form: suspension for injection, prolonged release, in pre-filled syringe
Active substance Dosage paliperidone palmitate 1560 mg -
It is used as maintenance treatment to combat the symptoms of schizophrenia in adult patients.
Dosage form: suspension for injection, prolonged release, in pre-filled syringe
Active substance Dosage paliperidone palmitate 1092 mg -
It is used to treat adult patients with multiple myeloma, a type of bone marrow cancer, when at least three other treatments have not worked.
Dosage form: solution for injection
Active substance Dosage ciltacabtagen autoleucel 3.2 X 10⁶ -1.0 X 10⁸ CELULAS -
It is used to treat a type of blood cell cancer called acute myeloid leukemia (AML) in adults.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage decitabine 50 mg -
It is used in adults to treat multiple myeloma (a cancer of the bone marrow), quiescent multiple myeloma, and AL amyloidosis (a blood and bone marrow disorder where abnormal proteins build up in the organs).
Dosage form: solution for injection
Active substance Dosage daratumumab 1800 mg -
It is used in adults aged 18 years or older to treat multiple myeloma, which is a type of bone marrow cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage daratumumab 100 mg -
It is used in adults aged 18 years or older to treat multiple myeloma, which is a type of bone marrow cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage daratumumab 400 mg -
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and adolescents aged 12 years and older who have never received HIV treatment. It must be taken in combination with other antiretroviral medicines.
Dosage form: tablets, film-coated
Active substance Dosage rilpivirine 25 mg -
It is used to treat adult men with prostate cancer that has metastasized and responds to testosterone-lowering treatments, or that has not metastasized and no longer responds to such treatments.
Dosage form: tablets, film-coated
Active substance Dosage apalutamide 240 mg -
It is used to treat adult men with prostate cancer that has metastasized and responds to testosterone-lowering treatments, or that has not metastasized and no longer responds to such treatments.
Dosage form: tablets, film-coated
Active substance Dosage apalutamide 60 mg -
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström's Macroglobulinemia (WM).
Dosage form: tablets, film-coated
Active substance Dosage ibrutinib 140 mg -
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström's Macroglobulinemia (WM).
Dosage form: capsules, hard
Active substance Dosage ibrutinib 140 mg -
It is used in adults to treat certain types of blood cancers, such as Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström Macroglobulinemia (WM).
Dosage form: tablets, film-coated
Active substance Dosage ibrutinib 280 mg -
It is used in adults to treat certain types of blood cancers, such as Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenström Macroglobulinemia.
Dosage form: tablets, film-coated
Active substance Dosage ibrutinib 420 mg -
It is used in adults to treat certain types of blood cancers: Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenström Macroglobulinemia (WM).
Dosage form: tablets, film-coated
Active substance Dosage ibrutinib 560 mg -
It is used for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and children aged 6 years or older who have already used other HIV medicines. It works by reducing the amount of virus in the body to improve the immune system.
Dosage form: tablets
Active substance Dosage etravirine 200 mg -
It is used to treat schizophrenia in adults and adolescents aged 15 years and older, and schizoaffective disorder in adults.
Dosage form: tablets, prolonged-release
Active substance Dosage paliperidone 3 mg -
It is used to treat schizophrenia in adults and adolescents aged 15 years and older, as well as schizoaffective disorder in adults.
Dosage form: tablets, prolonged-release
Active substance Dosage paliperidone 6 mg -
It is used to treat schizophrenia in adults and adolescents aged 15 years and older, and schizoaffective disorder in adults.
Dosage form: tablets, prolonged-release
Active substance Dosage paliperidone 9 mg -
It is used to treat type 2 diabetes in adults and in children aged 10 years and older. It helps reduce blood sugar by eliminating the excess through urine, which can help prevent heart disease and delay the decline of kidney function.
Dosage form: tablets, film-coated
Active substance Dosage canagliflozin 102,00 mg -
It is used for the treatment of adults and children aged 10 years and older with type 2 diabetes. It helps reduce blood sugar by eliminating it through the urine, which can help prevent heart disease and delay the decline of kidney function in patients with this condition.
Dosage form: tablets, film-coated
Active substance Dosage canagliflozin 306,00 mg -
It is used to treat adults with a type of lung cancer called advanced non-small cell lung cancer that has certain mutations in the EGFR gene. It is taken together with another medication called amivantamab.
Dosage form: tablets, film-coated
Active substance Dosage lazertinib 240 mg -
It is used to treat adults with a type of lung cancer called advanced non-small cell lung cancer that has certain mutations in the EGFR gene. It is taken together with another medication called amivantamab.
Dosage form: tablets, film-coated
Active substance Dosage lazertinib 80 mg -
It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps widen the pulmonary arteries to facilitate blood pumping from the heart, reducing blood pressure and relieving symptoms.
Dosage form: tablets, film-coated
Active substance Dosage macitentan 10 mg -
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and in children aged 3 years and older weighing at least 15 kg. It helps reduce the amount of virus in the body to improve the immune system.
Dosage form: suspension, oral
Active substance Dosage darunavir ethanolate 108.4 mg -
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and children aged 3 years and older weighing at least 40 kg. It helps reduce the amount of HIV in the body to improve the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir ethanolate 400 mg -
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and children aged 3 years and older weighing at least 15 kg who have previously used other antiretroviral drugs. It helps reduce the amount of HIV in the body to improve the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir ethanolate 600 mg -
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and children aged 3 years and older weighing at least 40 kg. It helps reduce the amount of HIV in the body to improve the immune system.
Dosage form: tablets, film-coated
Active substance Dosage darunavir ethanolate 867,28 mg -
It is used for the treatment of human immunodeficiency virus type 1 (HIV-1). It helps reduce the amount of virus in the body and keep it at low levels, thereby slowing damage to the immune system.
Dosage form: suspension for injection, prolonged release
Active substance Dosage rilpivirine 300 mg/ml -
It is used in adults to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also prescribed in adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage infliximab 100 mg -
It is used to treat adults and adolescents aged 12 years and older (weighing at least 40 kg) infected with HIV. It helps reduce the amount of HIV in the body and improves the immune system, although it is not a cure.
Dosage form: tablets, film-coated
Active substance Dosage darunavir ethanolate 867,28 mg cobicistat 150 mg -
It is used in adults with a type of lung cancer called non-small cell lung cancer, when the cancer has spread to other parts of the body and presents certain changes in a gene called EGFR. It may be prescribed as a first-line treatment in combination with lazertinib or when chemotherapy is no longer effective.
Dosage form: solution for injection
Active substance Dosage amivantamab 1600 mg -
It is used in adults with a type of lung cancer called non-small cell lung cancer, when the cancer has spread to other parts of the body and has certain genetic changes in a gene called EGFR. It may be used as first treatment in combination with lazertinib or when chemotherapy is no longer effective.
Dosage form: solution for injection
Active substance Dosage amivantamab 2240 mg -
It is used in adults with a type of lung cancer called non-small cell lung cancer, specifically when the cancer has spread to other parts of the body and presents certain mutations in the EGFR gene.
Dosage form: solution for infusion, concentrate
Active substance Dosage amivantamab 350 mg -
It is used in adults to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (which includes ankylosing spondylitis and non-radiographic axial spondyloarthritis), and ulcerative colitis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage golimumab 100 mg -
It is used in adults to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (which includes ankylosing spondylitis), and ulcerative colitis. It is also used in children aged 2 years and older for polyarticular juvenile idiopathic arthritis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage golimumab 50 mg -
It is used to treat multidrug-resistant pulmonary tuberculosis, which occurs when the disease affects the lungs and has stopped responding to other antibiotics. It must always be taken in conjunction with other tuberculosis medications.
Dosage form: tablets
Active substance Dosage bedaquiline fumarate 120,89 mg -
It is used in adults to reduce symptoms of depression (such as sadness, anxiety, difficulty sleeping, or changes in appetite) when two other antidepressants have not worked. It is also used to rapidly reduce symptoms in psychiatric emergency situations.
Dosage form: solution, nasal spray
Active substance Dosage esketamine hydrochloride 37,1 mg -
It is used to treat pulmonary arterial hypertension (PAH) to improve symptoms and the ability to perform physical activity, and also to treat digital ulcers in the fingers and toes of adults with scleroderma.
Dosage form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,082 mg -
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers in the fingers and toes in adults with scleroderma.
Dosage form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,541 mg -
It is used to treat moderate to severe Crohn's disease and moderate to severe ulcerative colitis in adults.
Dosage form: solution for infusion, concentrate
Active substance Dosage ustekinumab 135 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), Crohn's disease (in adults), and ulcerative colitis (in adults).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases in adults, such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg -
How should I store the medication?:
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases in adults, such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg